Replimune Group Inc (REPL)
10.80
-0.60
(-5.26%)
USD |
NASDAQ |
Nov 15, 16:00
10.80
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Free Cash Flow: -188.31M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -188.31M |
| June 30, 2024 | -192.93M |
| March 31, 2024 | -191.13M |
| December 31, 2023 | -176.27M |
| September 30, 2023 | -156.57M |
| June 30, 2023 | -144.83M |
| March 31, 2023 | -130.32M |
| December 31, 2022 | -120.98M |
| September 30, 2022 | -110.65M |
| June 30, 2022 | -100.43M |
| March 31, 2022 | -84.52M |
| December 31, 2021 | -77.70M |
| September 30, 2021 | -72.50M |
| June 30, 2021 | -66.36M |
| Date | Value |
|---|---|
| March 31, 2021 | -63.78M |
| December 31, 2020 | -59.48M |
| September 30, 2020 | -65.67M |
| June 30, 2020 | -69.17M |
| March 31, 2020 | -67.09M |
| December 31, 2019 | -62.37M |
| September 30, 2019 | -49.32M |
| June 30, 2019 | -34.95M |
| March 31, 2019 | -27.98M |
| December 31, 2018 | -24.33M |
| September 30, 2018 | -20.29M |
| June 30, 2018 | -17.60M |
| March 31, 2018 | -16.15M |
Free Cash Flow Range, Past 5 Years
-192.93M
Minimum
Jun 2024
-59.48M
Maximum
Dec 2020
-110.05M
Average
-92.48M
Median
Free Cash Flow Benchmarks
| Bristol-Myers Squibb Co | 13.80B |
| Nuvalent Inc | -153.27M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -31.50M |
| iBio Inc | -18.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -38.64M |
| Cash from Investing (Quarterly) | 0.458M |
| Cash from Financing (Quarterly) | -0.039M |
| Free Cash Flow Per Share (Quarterly) | -0.5183 |
| Free Cash Flow Yield | -24.81% |